Back to Search
Start Over
Latency reversal plus natural killer cells diminish HIV reservoir in vivo.
- Source :
-
Nature communications [Nat Commun] 2022 Jan 10; Vol. 13 (1), pp. 121. Date of Electronic Publication: 2022 Jan 10. - Publication Year :
- 2022
-
Abstract
- HIV is difficult to eradicate due to the persistence of a long-lived reservoir of latently infected cells. Previous studies have shown that natural killer cells are important to inhibiting HIV infection, but it is unclear whether the administration of natural killer cells can reduce rebound viremia when anti-retroviral therapy is discontinued. Here we show the administration of allogeneic human peripheral blood natural killer cells delays viral rebound following interruption of anti-retroviral therapy in humanized mice infected with HIV-1. Utilizing genetically barcoded virus technology, we show these natural killer cells efficiently reduced viral clones rebounding from latency. Moreover, a kick and kill strategy comprised of the protein kinase C modulator and latency reversing agent SUW133 and allogeneic human peripheral blood natural killer cells during anti-retroviral therapy eliminated the viral reservoir in a subset of mice. Therefore, combinations utilizing latency reversal agents with targeted cellular killing agents may be an effective approach to eradicating the viral reservoir.<br /> (© 2022. The Author(s).)
- Subjects :
- Animals
Bone Marrow drug effects
Bone Marrow immunology
Bone Marrow virology
CD4-Positive T-Lymphocytes drug effects
CD4-Positive T-Lymphocytes virology
Coculture Techniques
Female
HIV Infections genetics
HIV Infections immunology
HIV Infections virology
HIV-1 genetics
HIV-1 immunology
Host-Pathogen Interactions drug effects
Host-Pathogen Interactions genetics
Host-Pathogen Interactions immunology
Humans
Killer Cells, Natural transplantation
Male
Mice
Mice, Transgenic
Protein Kinase C genetics
Protein Kinase C immunology
Spleen drug effects
Spleen immunology
Spleen virology
Viral Load drug effects
Viremia genetics
Viremia immunology
Viremia virology
Virus Latency drug effects
Virus Replication drug effects
Anti-HIV Agents pharmacology
CD4-Positive T-Lymphocytes immunology
HIV Infections therapy
HIV-1 drug effects
Killer Cells, Natural immunology
Protein Kinase Inhibitors pharmacology
Viremia therapy
Subjects
Details
- Language :
- English
- ISSN :
- 2041-1723
- Volume :
- 13
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Nature communications
- Publication Type :
- Academic Journal
- Accession number :
- 35013215
- Full Text :
- https://doi.org/10.1038/s41467-021-27647-0